Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Fushenggong Pharmaceutical is a pharmaceutical manufacturing enterprise based in Meihekou, Jilin Province, China. Established in 2004, the company focuses on the research, development, and production of Traditional Chinese Medicine (TCM) and modern chemical drug formulations. Its product portfolio includes a wide range of dosage forms such as capsules, tablets, and granules, targeting therapeutic areas like cardiovascular health, respiratory diseases, and cerebrovascular conditions. The company operates GMP-certified facilities and maintains a significant presence in the Chinese domestic market through the distribution of essential medicines and natural health products. Notable products include Compound Salvia Tablets and Houttuynia Cordata preparations, which are widely utilized in clinical practice across China. As a private entity, it continues to expand its manufacturing capabilities to meet the growing demand for integrated healthcare solutions in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fushenggong.